Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Holding DRMA?
Track your performance easily

Dermata Therapeutics (DRMA) Cash flow

111 Followers

Dermata Therapeutics Cash Flow

DRMA's free cash flow for Q2 2024 was $-2.13M. For the 2024 fiscal year, DRMA's free cash flow was decreased by $2.43M and operating cash flow was $-2.13M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -7.75M$ -6.41M$ -8.83M$ -5.69M$ -4.03M$ -3.92M
Investing Cash Flow
------
Financing Cash Flow
$ 4.26M$ 7.61M$ 4.28M$ 15.96M$ 2.57M$ 4.73M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 26.24M$ 7.44M$ 10.80M$ 10.80M$ 530.40K$ 1.99M
Income Tax Paid Supplemental Data
$ 1.90K$ 950.00$ 950.00$ 1.40K$ 3.27K$ 1.14K
Interest Paid Supplemental Data
---$ 1.42K$ 56.71K$ 99.01K
Issuance Of Capital Stock
$ 4.33M$ 7.61M$ 4.28M$ 15.39M$ 268.75K$ 5.36M
Issuance Of Debt
---$ 1.01M$ 3.11M$ 150.00K
Repayment Of Debt
----$ -810.18K$ -776.17K
Free Cash Flow
$ -7.75M$ -6.41M$ -8.83M$ -5.69M$ -4.03M$ -3.92M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Dermata Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis